HOUSTON, April 06, 2018 -- VAALCO Energy, Inc. (NYSE:EGY) today announced Chief Executive Officer Cary Bounds and Chief Financial Officer Phil Patman Jr. will attend IPAA Oil & Gas Investment Symposium (OGIS) in New York City and the Company will be presenting at the conference on April 10, 2018 at 2:05pm ET and also host one-on-one meetings. In conjunction with the conference, a live webcast of this presentation and an updated investor deck will be available on VAALCO’s website (www.vaalco.com) under the Investor Relations tab (Webcasts/Presentations section) on the date of the presentation.
About VAALCO
VAALCO Energy, Inc. is a Houston-based independent energy company principally engaged in the acquisition, development and production of crude oil. The Company's properties and acreage are located primarily in Gabon and Equatorial Guinea in West Africa.
Investor Contact
Phil Patman Jr. 713-623-0801


Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Apple Restores Telegram to App Store After Content Policy Violation
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 



